Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-056960
Filing Date
2021-09-20
Accepted
2021-09-20 19:41:30
Documents
2
Period of Report
2021-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1588
2 POA DOCUMENT poa.txt EX-24.3_1009307 3134
  Complete submission text file 0001209191-21-056960.txt   6135
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011
Business Address
Burgess Julie (Reporting) CIK: 0001883722 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40288 | Film No.: 211264464